Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

germline polymorphisms in xenobiotic metabolism genes in toxicity profile

Outcome Time Frame:

36 months

Safety Issue:

Yes

Principal Investigator

won ki kang, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Samsung Medical Center

Authority:

Korea: Food and Drug Administration

Study ID:

2008-05-053

NCT ID:

NCT01470404

Start Date:

July 2008

Completion Date:

Related Keywords:

• Gastric Cancer
• Stomach Neoplasms

Name	Location